SCHEDULE 13G: Janus Henderson Group Discloses 5.7% Stake in Maze Therapeutics
Beneficial Ownership Report
Janus Henderson Group plc has filed a Schedule 13G, reporting a beneficial ownership of 5.7% of Maze Therapeutics, Inc.'s common stock as of March 31, 2025.
Summary
- Janus Henderson Group plc reported beneficial ownership of 2,498,111 shares of Common Stock in Maze Therapeutics, Inc.
- This stake represents 5.7% of the total class of securities.
- The filing indicates shared voting power and shared dispositive power over all 2,498,111 reported shares.
- The shares are held in the ordinary course of business and were not acquired for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine regulatory filing disclosing beneficial ownership by an institutional investor, with no explicit positive or negative implications for the issuer's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a standard disclosure by an institutional investment manager, Janus Henderson Group plc, indicating a passive stake in Maze Therapeutics, Inc. It reflects a routine portfolio holding rather than a strategic or activist investment, consistent with the nature of a Schedule 13G filing by a qualified institutional investor.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, confirming a large asset manager's stake in the company.
Key Dates
| Date | Description |
|---|---|
| 2022-12-09 | Date of Power of Attorney execution by Janus Henderson Group plc for filing purposes. |
| 2025-03-31 | Date of the event which requires the filing of this statement, indicating the beneficial ownership position. |
| 2025-05-14 | Date the Schedule 13G statement was signed by Kristin Mariani. |
Keywords
Maze Therapeutics, Janus Henderson Group, Common Stock, SEC filing, Schedule 13G, beneficial ownership, institutional investment, investment adviser, holding company
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.